These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7149441)

  • 21. ["In vitro" interactions between influenza virus and mouse lung alveolar macrophages (author's transl)].
    Lemercier G; Mavet S; Burckhart MF; Fontanges R
    Ann Microbiol (Paris); 1979 Jan; 130 A(1):119-32. PubMed ID: 475216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alveolar macrophage dysfunction associated with viral pneumonitis.
    Jakab GJ; Warr GA; Sannes PL
    Adv Exp Med Biol; 1979; 121B():81-90. PubMed ID: 546137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the elastase inhibitor, eglin-c, on antibacterial mechanisms in experimental pneumonia. Description of a system to quantitate phagocytic and bactericidal activity of resident murine alveolar macrophages in vivo.
    Esposito AL; Quinn LA; Lucey EC; Snider GL
    Am Rev Respir Dis; 1987 Mar; 135(3):676-81. PubMed ID: 3644606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in lung macrophage antimicrobial activity associated with viral pneumonia.
    Warr GA; Jakab GJ
    Infect Immun; 1979 Nov; 26(2):492-7. PubMed ID: 232689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages.
    Warshauer D; Goldstein E; Akers T; Lippert W; Kim M
    Am Rev Respir Dis; 1977 Feb; 115(2):269-77. PubMed ID: 842940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia.
    Jakab GJ; Warr GA; Sannes PL
    Infect Immun; 1980 Mar; 27(3):960-8. PubMed ID: 6247283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alveolar lining material on phagocytic and bactericidal activity of lung macrophages against Staphylococcus aureau.
    LaForce FM
    J Lab Clin Med; 1976 Nov; 88(5):691-9. PubMed ID: 978037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of pulmonary defense mechanisms against viral and bacterial infections by acute exposures to nitrogen dioxide.
    Jakab GJ
    Res Rep Health Eff Inst; 1988 Nov; (20):1-38. PubMed ID: 2855873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the alveolar macrophage in pulmonary bacterial defense.
    Goldstein E; Bartlema HC
    Bull Eur Physiopathol Respir; 1977; 13(1):57-67. PubMed ID: 321054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective down-regulation of alveolar macrophage oxidative response to opsonin-independent phagocytosis.
    Kobzik L; Godleski JJ; Brain JD
    J Immunol; 1990 Jun; 144(11):4312-9. PubMed ID: 2160498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylprednisolone impairs the bactericidal activity of alveolar macrophages.
    White JC; Lanser ME; Nelson S; Jakab GJ
    J Surg Res; 1985 Jul; 39(1):46-52. PubMed ID: 4010275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages.
    Musher DM; Watson DA; Nickeson D; Gyorkey F; Lahart C; Rossen RD
    Am J Med Sci; 1990 Mar; 299(3):158-63. PubMed ID: 2316560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell phenomena in experimental viral-bacterial infections in mice. II. Phagocytic activity of granulocytes during infection with influenza viruses and staphylococci.
    Kowalska M; Szydłowska T; Denys A; Białek J
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):453-6. PubMed ID: 2830857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of opsonins on the bactericidal effect of bovine alveolar macrophages against Pasteurella multocida.
    Ashfaq MK; Campbell SG
    Cornell Vet; 1986 Apr; 76(2):213-21. PubMed ID: 3698603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin-induced suppression of lung host defenses.
    Nelson S; Chidiac C; Bagby G; Summer WR
    J Med; 1990; 21(1-2):85-103. PubMed ID: 2120377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection.
    Stein-Streilein J; Guffee J
    J Immunol; 1986 Feb; 136(4):1435-41. PubMed ID: 3944461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus.
    Rodgers BC; Mims CA
    Infect Immun; 1982 Jun; 36(3):1154-9. PubMed ID: 6178688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia.
    Jakab GJ; Green GM
    J Clin Invest; 1973 Nov; 52(11):2878-84. PubMed ID: 4356001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alveolar macrophage phagocytic kinetics following pulmonary parainfluenza-3 virus infection.
    Slauson DO; Lay JC; Castleman WL; Neilsen NR
    J Leukoc Biol; 1987 May; 41(5):412-20. PubMed ID: 3033112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of pulmonary antibacterial defense mechanisms by halothane anesthesia.
    Manawadu BR; LaForce FM
    Chest; 1979 Feb; 75(2 Suppl):242-3. PubMed ID: 436467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.